2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast CancerBreast Cancer RecurrentActive, not recruitingPhase 32026-09-03NCT03820830
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingNot applicable2026-02-09NCT02308085